05/26/2022
State of the art technologies related to ophthalmic treatment
Regenerative medicine
Research on applications of iPS cells to ophthalmic treatment is under way, including transplantation of retinal pigment epithelial cells for treating age-related macular degeneration, and transplantation of retinal tissues for treating retinitis pigmentosa or corneal epithelial cells. There are high public expectations for progress in clinical applications of these emerging technologies.
Gene therapy
Research on gene therapy for retinitis pigmentosa has made progress. The development of regenerative medicine and gene therapy is expected to turn retinitis pigmentosa as a hereditary disease without currently effective treatments into a treatable disease.
